ArticleJournal of Cancer2018

Risk of immune-related colitis with PD-1/PD-L1 inhibitors vs chemotherapy in solid tumors: systems assessment.

Qiang Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.